Understanding Cancer: Metastasis, Stages of Cancer, and More
Not Helpful 0 Helpful Three weeks later the pain in my back and side was gone and my bowels had improved. This site is not responsible for the contents of any off-site web pages, companies or persons linked or referenced in this site. The standard procedure for skin cancer treatment in US hospitals is surgery, chemotherapy, and even radiation, with no significant cure rate! Vitamin A is also an antioxidant, and helps your immune system to function more efficiently. Most attack the DNA within cancer cells, preventing them from dividing and causing them to self-destruct. There are a number of particular foods that can help.
Tips, Information, and Support
In healthy individuals, NK cells routinely kill cancers while tumors are microscopic and before they are detectable. Measurements of NK cell cancer killing function are considered primary indicators of clinical prognosis.
Research shows that NK cell cancer killing function is often low in those with a family history of cancer, declines with age, corresponding with age-related increases in the incidence of cancer, and is suppressed by cancer surgery, radiation and chemotherapy, offering an explanation of why cancer metastasis seem to spread more aggressively following these treatments.
Stimulating NK cell function and supporting the immune system's front-line defense has become one of the most promising avenues of cancer treatment and prevention.
Since , there have been 29 published scientific studies showing that the use of a proprietary natural compound called AHCC Active Hexose Correlated Compound , can increase NK cell cancer killing function by several hundred times.
Among the benefits of using AHCC, as experienced by a majority of cancer patients in several human clinical trials, is substantial improvement in the functioning of macrophages, another type of cytotoxic white blood cell that clears debris from cell damage, directly attacks disease causing cells, and displays antigens which stimulate antibody production by B-cell white blood cells. AHCC also helps increase the production of specific cytokines, immune system chemical messengers, that include:.
There is a bewildering choice of immune enhancing natural supplements available. Unfortunately, the proof for most of these fall short of true consumer use conditions. For example, there are numerous mouse and rat studies. From this animal research we are supposed to infer results in humans.
In other studies involving humans the researchers may use an intravenous route of administration, whereas in the "real world," users will be expected to take it orally. In some instances, results are from one researcher only, without independent confirmation. Therefore, one of the most important attributes of AHCC may be the strength and extent of the research that demonstrate its beneficial effects. It is supported by multiple studies reviewed for publication in professional peer journals, involving hundreds of human patients, all taking the product by mouth, and using many groups of scientific investigators who independently verify and validate one another's results.
This gives doctors and patients a confident, reliable profile of this supplement's mechanism of action, scope of effect and safety profile. The study design tracked consecutive patients following "curative" surgery for primary liver cancer from February to September A treatment group consisting of 70 patients received 3 grams of AHCC per day; the balance were a matched "control" group that had surgery only.
The object of the study was to see how AHCC would effect the over-all survival of patients with liver cancer and the pattern of reoccurrence. AHCC is not battling cancer or a cancerous tumor directly. It is strengthening the immune system, so it can do what it is supposed to do - destroy cancer cells! This helps explain why the compound is effective for more than just liver cancer. Three prostate, three ovarian, two multiple myeloma and three breast cancer patients had their tumor associated antigen TAA markers measured before, during and after taking AHCC.
The results speak for themselves: The level of CA in two breast cancer patients did not change significantly, although the CEA in one of the breast patients did see significant reduction. Other important data to come from this trial includes the Natural Killer Cell activity level. Nine of the eleven patients had dramatic increase in the NK cell activity level as well as their T and B cell activity level.
In other words, the patient's reduction in tumor markers correlated with the increases in strength of their immune systems, validating the notion that a strong immune system can help fight cancer. It is worth repeating that none of the patients participating in any of the clinical trials, where Active Hexose Correlated Compound was administered at the therapeutic dose, observed any side effects or toxicity.
Remember, there are many chemicals available that have the ability to shrink tumors, but at what price? There is a big "risk-reward relationship" in cancer therapy and finding nontoxic compounds like AHCC, which carries virtually no risk, with the possibility of a great reward, is a long sought goal of cancer research.
Most cancer patients use natural therapies to complement conventional anti-cancer therapies, so a study published in in the prestigious journal Anti-Cancer Drugs showing how AHCC worked in combination with a widely used form of oral chemotherapy is particularly important. This study demonstrated that AHCC enhanced the beneficial effects of the chemotherapy, while reducing detrimental side effects. The Anti-Cancer Drugs study concluded, "Taken together, the combination of Active Hexose Correlated Compound, plus chemotherapy, brought about good therapeutic effects, not only on primary tumor growth, but also on reducing metastasis and these effects were mediated by host immunity which was restored or activated by Active Hexose Correlated Compound.
The Japanese have traditionally used natural compounds from mushrooms to support the immune system. Chemotherapy can temporarily reduce the number of neutrophils in the body, making it harder for you to fight infections. Radiotherapy to the lung can damage the hairs and mucus producing cells that help to remove bacteria. Your normal neutrophil count is between 2, and 7, per cubic millimetre of blood. When you don't have enough neutrophils in your blood, doctors may say that you are neutropaenic.
This means that you usually don't have to avoid contact with your family, friends or children after treatment. This is why you usually only get some infectious diseases, such as measles or chicken pox, once. Vaccination works by using this type of immunity. A vaccine contains a small amount of protein from a disease. This is not harmful, but it allows the immune system to recognise the disease if it meets it again. The immune response can then stop you getting the disease.
Some vaccines use small amounts of the live bacteria or virus. These are live attenuated vaccines. Lymphocytes are a type of white blood cells involved in the acquired immune response. There are 2 main types of lymphocytes:. The bone marrow produces all blood cells, including B and T lymphocytes. B cells mature in the bone marrow. But T cells mature in the thymus gland.
Once they are fully mature, the B and T cells travel to the spleen and lymph nodes ready to fight infection. B cells react against invading bacteria or viruses by making proteins called antibodies. The antibody made is different for each different type of germ bug.
The antibody locks onto the surface of the invading bacteria or virus. Antibodies can also detect and kill damaged cells. The B cells are part of the memory of the immune system.
They are able to make their antibody very quickly. Antibodies have 2 ends. One end sticks to proteins on the outside of white blood cells. The other end sticks to the germ or damaged cell and helps to kill it. The end of the antibody that sticks to the white blood cell is always the same. Scientists call this the constant end. The end of the antibody that recognises germs and damaged cells varies, depending on the cell it needs to recognise.
So it is called the variable end.